28 August 2017
Visiongain’s new report the Brain Monitoring Devices Market Forecast 2017-2027: Revenue Prospects by Device Type (Invasive & Non-Invasive), Product (EEG, CT, MRI, MEG, Others), Application (TBI, Epilepsy, Stroke, Others) and End-User (Hospitals, Neurological Centres, Other) indicates that the global brain monitoring devices market will see over $9bn in revenue in 2017.
The lead analyst of the report said:
“The brain monitoring devices market is expected to grow at a healthy CAGR over the study forecast period. The key drivers supporting the growth of the market are increasing prevalence and incidence neurological disorders such as epilepsy, stroke, and traumatic brain injuries. In addition, the increasing geriatric population, increasing awareness of brain function monitoring, and technological advancements in monitoring devices is further expected to fuel market growth. However, factors such as high cost of devices, lack of skilled labour force, and under penetration of diagnostics procedures in developing countries are likely to hinder the growth of the market in the near future.”
The 155-page report contains 119 tables, charts and graphs that add visual analysis in order to explain developing trends within the brain monitoring devices market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading brain monitoring devices submarkets, segmented by device type, with forecasts for invasive and non-invasive brain monitoring devices. The market is also segmented by product, and includes forecasts for Electroencephalogram (EEG), Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Magnetoencephalogram (MEG) and other brain monitoring devices. The report also includes forecasts for the applications of brain monitoring devices, including traumatic brain injuries (TBI), epilepsy, stroke and others. In addition, the report also contains forecasts for the brain monitoring devices market by end-user, including hospitals neurological centres and others.
The 155-page report offers market forecasts and analysis for 12 national markets, as well as the rest of the world, market. In addition, the report contains a dedicated leading companies’ chapter covering 10 companies leading the field in brain monitoring devices technology.
The Brain Monitoring Devices Market Forecast 2017-2027: Revenue Prospects by Device Type (Invasive & Non-Invasive), Product (EEG, CT, MRI, MEG, Others), Application (TBI, Epilepsy, Stroke, Others) and End-User (Hospitals, Neurological Centres, Other) report will be of value to anyone who wants to better understand the brain monitoring devices market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the brain monitoring devices industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.